Terms: = Bone cancer AND ATRX, P46100, ZNF-HX, XNP, XH2, SHS, SFM1, RAD54, MRXHF1, MGC2094, ATR2, 546 AND Treatment
47 results:
1. Factors associated with prolonged progression-free survival of patients treated with first-line afatinib for advanced epidermal growth factor receptor-mutated non-small cell lung cancer.
Chiu LC; Hsu PC; Wang CC; Ko HW; Kuo SC; Ju JS; Tung PH; Huang AC; Yang CT
Thorac Cancer; 2024 Mar; 15(7):529-537. PubMed ID: 38279515
[TBL] [Abstract] [Full Text] [Related]
2. Deciphering the Signaling Mechanisms of Osteosarcoma Tumorigenesis.
Nirala BK; Yamamichi T; Yustein JT
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511127
[TBL] [Abstract] [Full Text] [Related]
3. Clinical Targeted Next-Generation Panel Sequencing Reveals
Marinoff AE; Spurr LF; Fong C; Li YY; Forrest SJ; Ward A; Doan D; Corson L; Mauguen A; Pinto N; Maese L; Colace S; Macy ME; Kim A; Sabnis AJ; Applebaum MA; Laetsch TW; Glade-Bender J; Weiser DA; Anderson M; Crompton BD; Meyers P; Zehir A; MacConaill L; Lindeman N; Nowak JA; Ladanyi M; Church AJ; Cherniack AD; Shukla N; Janeway KA
JCO Precis Oncol; 2023 Mar; 7():e2200334. PubMed ID: 36996377
[TBL] [Abstract] [Full Text] [Related]
4. [Mutation characteristics of osteosarcoma: a single center study of 64 cases using next-generation sequencing].
Gao DL; Dong RF; Liu WF; Gong LH; Xu HR; Niu XH; Ding Y
Zhonghua Bing Li Xue Za Zhi; 2023 Apr; 52(4):370-375. PubMed ID: 36973198
[No Abstract] [Full Text] [Related]
5. Distribution of lymphoma subtypes in Ukraine according to the WHO 2016 classification.
Kriachok I; Stepanishyna Y; Skrypets T; Shokun N; Martynchyk A; Tytorenko I; Aleksik O; Krotevych M; Manni M; Federico M
Hematol Oncol; 2023 Feb; 41(1):196-200. PubMed ID: 35932211
[TBL] [Abstract] [Full Text] [Related]
6. Intracranial high-grade glioma with malignant progression of spinal intramedullary metastasis: an atypical presentation with review of literature.
Siroya HL; Bhagavatula ID; Bhat DI; Sadashiva N
Br J Neurosurg; 2023 Dec; 37(6):1495-1501. PubMed ID: 34396889
[TBL] [Abstract] [Full Text] [Related]
7. Accuracy and precision of the spinal instability neoplastic score (SINS) for predicting vertebral compression fractures after radiotherapy in spinal metastases: a meta-analysis.
Kim YR; Lee CH; Yang SH; Hyun SJ; Kim CH; Park SB; Kim KJ; Chung CK
Sci Rep; 2021 Mar; 11(1):5553. PubMed ID: 33692442
[TBL] [Abstract] [Full Text] [Related]
8. Having a co-morbidity predicts worse outcome in early rheumatoid arthritis despite intensive treatment: a post hoc evaluation of the pragmatic randomized controlled CareRA trial.
Stouten V; Westhovens R; De Cock D; Van der Elst K; Pazmino S; Bertrand D; Joly J; Verschueren P
Rheumatology (Oxford); 2021 Aug; 60(8):3699-3708. PubMed ID: 33434277
[TBL] [Abstract] [Full Text] [Related]
9. Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapy.
Turiello R; Capone M; Giannarelli D; Morretta E; Monti MC; Madonna G; Mallardo D; Festino L; Azzaro R; Levesque MP; Imhof L; Weide B; Amaral T; Chevrier M; Sucker A; Rutkowski P; Schadendorf D; Lebbe C; Luke JJ; Wistuba-Hamprecht K; Dummer R; Pinto A; Morello S; Ascierto PA
J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33361405
[TBL] [Abstract] [Full Text] [Related]
10. Impact of COVID-19 on anxiety levels among patients with cancer actively treated with systemic therapy.
Sigorski D; Sobczuk P; Osmola M; Kuć K; Walerzak A; Wilk M; Ciszewski T; Kopeć S; Hryń K; Rutkowski P; Stec R; Szczylik C; Bodnar L
ESMO Open; 2020 Oct; 5(5):e000970. PubMed ID: 33097653
[TBL] [Abstract] [Full Text] [Related]
11. Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study.
Cavo M; Gay F; Beksac M; Pantani L; Petrucci MT; Dimopoulos MA; Dozza L; van der Holt B; Zweegman S; Oliva S; van der Velden VHJ; Zamagni E; Palumbo GA; Patriarca F; Montefusco V; Galli M; Maisnar V; Gamberi B; Hansson M; Belotti A; Pour L; Ypma P; Grasso M; Croockewit A; Ballanti S; Offidani M; Vincelli ID; Zambello R; Liberati AM; Andersen NF; Broijl A; Troia R; Pascarella A; Benevolo G; Levin MD; Bos G; Ludwig H; Aquino S; Morelli AM; Wu KL; Boersma R; Hajek R; Durian M; von dem Borne PA; Caravita di Toritto T; Zander T; Driessen C; Specchia G; Waage A; Gimsing P; Mellqvist UH; van Marwijk Kooy M; Minnema M; Mandigers C; Cafro AM; Palmas A; Carvalho S; Spencer A; Boccadoro M; Sonneveld P
Lancet Haematol; 2020 Jun; 7(6):e456-e468. PubMed ID: 32359506
[TBL] [Abstract] [Full Text] [Related]
12. Scintigraphic load of bone disease evaluated by DASciS software as a survival predictor in metastatic castration-resistant prostate cancer patients candidates to 223RaCl treatment.
Frantellizzi V; Pani A; Ippoliti MD; Farcomeni A; Aloise I; Colosi M; Polito C; Pani R; Vincentis G
Radiol Oncol; 2019 Dec; 54(1):40-47. PubMed ID: 31855572
[TBL] [Abstract] [Full Text] [Related]
13. What is the Likelihood That Tumor Endoprostheses Will Experience a Second Complication After First Revision in Patients With Primary Malignant bone Tumors And What Are Potential Risk Factors?
Theil C; Röder J; Gosheger G; Deventer N; Dieckmann R; Schorn D; Hardes J; Andreou D
Clin Orthop Relat Res; 2019 Dec; 477(12):2705-2714. PubMed ID: 31764339
[TBL] [Abstract] [Full Text] [Related]
14. Five-year trends of bone scan and prostate-specific membrane antigen positron emission tomography utilization in prostate cancer: A retrospective review in a private centre.
Haran C; McBean R; Parsons R; Wong D
J Med Imaging Radiat Oncol; 2019 Aug; 63(4):495-499. PubMed ID: 30972933
[TBL] [Abstract] [Full Text] [Related]
15. Time-to-event Outcomes in Men with Nonmetastatic Castrate-resistant Prostate cancer-A Systematic Literature Review and Pooling of Individual Participant Data.
Aly M; Hashim M; Heeg B; Liwing J; Leval A; Mehra M; Lawson J; Brookman-May SD; Akre O
Eur Urol Focus; 2019 Sep; 5(5):788-798. PubMed ID: 29627197
[TBL] [Abstract] [Full Text] [Related]
16. Intravoxel incoherent motion diffusion-weighted MR imaging for differentiation of benign and malignant musculoskeletal tumours at 3 T.
Lim HK; Jee WH; Jung JY; Paek MY; Kim I; Jung CK; Chung YG
Br J Radiol; 2018 Feb; 91(1082):20170636. PubMed ID: 29144153
[TBL] [Abstract] [Full Text] [Related]
17. Gamma Knife Radiosurgery for Petroclival Meningioma: Long-Term Outcome and Failure Pattern.
Kim JW; Kim DG; Se YB; Kim SK; Chung HT; Paek SH; Jung HW
Stereotact Funct Neurosurg; 2017; 95(4):209-215. PubMed ID: 28683438
[TBL] [Abstract] [Full Text] [Related]
18. Effect of antithymocyte globulin source on outcomes of bone marrow transplantation for severe aplastic anemia.
Kekre N; Zhang Y; Zhang MJ; Carreras J; Ahmed P; Anderlini P; Atta EH; Ayas M; Boelens JJ; Bonfim C; Deeg HJ; Kapoor N; Lee JW; Nakamura R; Pulsipher MA; Eapen M; Antin JH
Haematologica; 2017 Jul; 102(7):1291-1298. PubMed ID: 28341733
[TBL] [Abstract] [Full Text] [Related]
19. Significance of recurrence of minimal residual disease detected by multi-parameter flow cytometry in patients with acute lymphoblastic leukemia in morphological remission.
Pemmaraju N; Kantarjian H; Jorgensen JL; Jabbour E; Jain N; Thomas D; O'Brien S; Wang X; Huang X; Wang SA; Konopleva M; Konoplev S; Kadia T; Garris R; Pierce S; Garcia-Manero G; Cortes J; Ravandi F
Am J Hematol; 2017 Mar; 92(3):279-285. PubMed ID: 28052371
[TBL] [Abstract] [Full Text] [Related]
20. Prediction of Hearing Loss Due to Cisplatin Chemoradiotherapy.
Theunissen EA; Zuur CL; Józwiak K; Lopez-Yurda M; Hauptmann M; Rasch CR; van der Baan S; de Boer JP; Dreschler WA; Balm AJ
JAMA Otolaryngol Head Neck Surg; 2015 Sep; 141(9):810-5. PubMed ID: 26291150
[TBL] [Abstract] [Full Text] [Related]
[Next]
